Theodore Chiacchio

Theodore Chiacchio

Theodore Chiacchio has been practicing Intellectual Property law for over 15 years. He counsels clients regarding all manner of patent and other Intellectual Property issues. Mr. Chiacchio also monetizes his clients’ intellectual property assets for them. He has spent well over a decade litigating patent and other Intellectual Property disputes on behalf of his clients. He also prepares and prosecutes patent applications on behalf of his clients. Mr. Chiacchio’s experience spans a wide range of technology areas, but he has particular expertise with matters involving the pharmaceutical arts.


Posts by Theodore Chiacchio


Patent Eligibility Determinations in Life Sciences Patent Cases

This article examines Supreme Court and Federal Circuit analyses of patent eligibility under 35 U.S.C. § 101 where the patent claims at issue were directed to Life Sciences-related …
By Theodore Chiacchio
26 days ago 3

Federal Circuit Treatment of Inherency Arguments Aimed at Method of Treatment Patent Claims

This article examines Federal Circuit case law analyzing validity challenges to method of treatment patent claims where the claims at issue are alleged to recite an inherent …
By Theodore Chiacchio
2 months ago 5

The Federal Circuit’s Approach to the Infringement Analysis in Hatch-Waxman Cases

35 U.S.C. § 271(e)(2) provides that it shall be an act of infringement to submit an Abbreviated New Drug Application (“ANDA”) “if the purpose of such submission …
By Theodore Chiacchio
3 months ago 3

Examining CAFC Application of §271(g)(1)’s ‘Materially Changed’ Exception to Infringement Liability

35 U.S.C. § 271(g) was enacted in 1988 as part of the Process Patents Amendments Act to address instances where would-be infringers were avoiding infringement liability by using …
By Theodore Chiacchio
5 months ago 0

Analyzing obviousness and anticipation challenges to claims directed to an isolated component of a prior art mixture

Based on the governing Federal Circuit case law, where the patent claim at issue is directed to a specific component (such as a specific enantiomer) of a …
By Theodore Chiacchio
6 months ago 1

Avoiding drug development clinical trials from being an invalidating public use

The legal principles set out above, while seemingly straight-forward enough, leave ample room for case-specific interpretation and application when it comes to the question of whether the …
By Theodore Chiacchio
8 months ago 4

A review of enhanced damages since Halo: Minimizing potential exposure to enhanced damages

Since the Supreme Court’s decision in Halo, there have been approximately 100 cases analyzing whether the adjudged infringer acted egregiously/willfully en route to a determination of …
By Theodore Chiacchio
10 months ago 0

Our website uses cookies to provide you with a better experience. Read our privacy policy for more information.Accept and Close